# Progress Note 05 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Elizabeth Barrett Browning (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI026-SYN-TD
- Date: 1845-07-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Clementine Haverford-Asante, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic adult preventive visit. **S**

## History of present illness

Ms. Barrett Browning is a 39-year-old poet with bronchiectasis diagnosed four months ago, long-term morphine therapy that she is slowly reducing by her own choice, and prolonged grief disorder in weekly grief therapy, who comes for her yearly preventive visit. She does airway clearance twice a day, and her sputum is down to about a tablespoon a day without blood. She takes morphine solution 4 mL (8 mg) twice daily, reduced in two steps from 5 mL since April. She has been out by car twice this summer and walked in the garden. She is writing well and has finished a set of poems she began in the spring. Her periods are regular. She has no new concerns. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 39 |
| Lungs | Stable on airway clearance; no exacerbation since diagnosis |
| Medicines | Morphine solution 8 mg twice daily; naloxone at home; vitamin D3 1819 units daily |
| Mood | PHQ-2 1; finishing the sixteenth grief therapy session this week |

## Health risk assessment

Completed by the patient on paper at home and reviewed with her by Dr. Haverford-Asante. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Fair, and better than in the spring |
| Psychosocial | Absorbing work and many correspondents; grief easing; financially secure |
| Substance use | AUDIT-C 0; prescribed morphine taken as directed; no other drugs |
| Tobacco | Never uses tobacco; no smokers in her room |
| Physical activity | Home exercise program three days a week; walks in the garden in fine weather |
| Nutrition | Small frequent meals and one supplement drink a day; dairy daily |
| Sleep | About six hours, better than in the spring |
| Safety | No falls; morphine kept locked; naloxone at home; no firearm at home; feels safe at home (intimate partner violence screen negative) |
| Sexual and reproductive health | Not sexually active; not planning pregnancy; periods regular |
| Activities of daily living | Independent |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or weight loss; weight rising |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No sinus pain or discharge |
| Cardiovascular | Negative | Occasional palpitations, less often than in the spring; no chest pain or ankle swelling |
| Respiratory | Positive | Morning cough with about a tablespoon of sputum; no blood since the first month; breathless on the second flight of stairs |
| Gastrointestinal | Positive | Stools firm every two days on morphine; no abdominal pain |
| Genitourinary | Negative | Regular periods; no urinary symptoms |
| Musculoskeletal | Positive | Mild upper back ache at the end of a long day of writing, as for many years; no new pain |
| Integumentary | Negative | No rashes or changing moles |
| Breast | Negative | No lump, pain or nipple discharge |
| Neurological | Negative | No drowsiness, headaches or weakness |
| Psychiatric | Negative | Mood better; no thoughts of self-harm; PHQ-2 1 |

12 systems reviewed. **S**

## Current medications

- Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeat in 2 to 3 minutes in the other nostril if no response; call 911 **S**
- Cholecalciferol (vitamin D3) 1000 unit (25 mcg) oral tablet, two tablets (1819 units) by mouth daily **S**
- Morphine sulfate 2 mg/mL oral solution, 4 mL (8 mg) by mouth twice daily, morning and bedtime (16 mg a day) **S**

## Allergies

- No known allergy **S**

## Objective

BP 106/66 mmHg; pulse 82 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 43.8 kg; BMI 17.8 kg/m². All vital signs are synthetic.

PHQ-2: 1; AUDIT-C: 0. All results are synthetic.

## Immunizations given today

- Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) **S**
- Pneumococcal conjugate vaccine, 20-valent (PCV20) **S**
- Hepatitis B vaccine (HepB-CpG), dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Thin but well; weight 43.8 kg, BMI 17.8; blood pressure 106/66 |
| Skin | No suspicious moles |
| Neck | Thyroid normal; no nodes |
| Breasts | Clinical breast examination declined; no concerns raised |
| Cardiovascular | Regular rhythm; no murmur; no ankle edema |
| Respiratory | A few coarse crackles at the left base that clear partly with coughing; no wheeze |
| Abdomen | Soft and non-tender |
| Musculoskeletal | Mild thoracic kyphosis; no spinal tenderness |
| Pelvic | Speculum examination with a chaperone present; cervix normal; sample taken for HPV testing |
| Psychiatric | Bright, engaged, and able to speak of her brother briefly without distress overwhelming her |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated. Tdap, PCV20 and the first hepatitis B dose given today; hepatitis B and C screening sent; cervical HPV test collected. HIV was tested at her first visit. **S**
   - First screening mammogram at 40, next year.
   - Next preventive visit in one year.
2. **Long-term opioid therapy** (Z79.891). Benefits and harms reviewed: no sedation, constipation controlled, naloxone at home, the prescription monitoring program shows one prescriber and one pharmacy. She wants to stay at 8 mg twice daily over the summer before the next step. **S**
   - Continue morphine solution 4 mL twice daily.
   - Senna at night if stools go more than three days.
3. **Prolonged grief disorder: safety review** (F43.81). No thoughts of death or self-harm; the safety plan is current. **S**
   - Final grief session this week, with a booster session in two months.
   - 988 Suicide & Crisis Lifeline on her safety plan.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 106/66 mmHg |
| Depression screening | Completed today | PHQ-2 score 1; already in treatment for grief with PHQ-9 at each chronic-care visit |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 0 |
| Tobacco use | Completed today | Never uses tobacco |
| Intimate partner violence screening | Completed today | Negative; feels safe at home |
| Lipid screening and statin assessment | Not indicated | Statin assessment begins at 40; no risk factors |
| Diabetes screening | Not indicated | Underweight, with a normal glucose at her first visit |
| Breast cancer screening | Due | Biennial mammography from 40, next year |
| Cervical cancer screening | Completed today | No record of earlier screening; high-risk HPV test collected today; repeat every five years if negative |
| Colorectal cancer screening | Not indicated | Begins at 45 |
| HIV screening | Up to date | Negative at her first visit, as part of the tuberculosis work-up |
| Hepatitis C screening | Completed today | Once for adults 18 to 79; sent today |
| Hepatitis B screening | Completed today | Once for all adults (surface antigen, surface antibody and core antibody); sent today before the first vaccine dose |
| Osteoporosis screening | Up to date | DXA three months ago: Z-scores within the expected range; vitamin D repleted |
| Folic acid | Not indicated | Not sexually active and not planning pregnancy; she will start folic acid and review her medicines before any pregnancy |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap; no record of a booster within ten years |
| Pneumococcal vaccine | Completed today | PCV20 for chronic lung disease; series complete |
| Hepatitis B vaccine | Completed today | No record of vaccination; dose 1 of 2 today, dose 2 at the autumn review |
| Influenza vaccine | Due | At the autumn review; yearly for her lung disease |
| COVID-19 vaccine | Due | Discuss in the autumn with the influenza vaccine |
| Human papillomavirus vaccine | Not indicated | Routine vaccination ends at 26; shared decision-making to 45: not sexually active, and she chose not to have it |
| Naloxone and opioid safety | Up to date | Two naloxone devices at home and in date; morphine in a locked box |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She wants full treatment of any chest infection or bleeding, including hospital care, and would want her poems and papers kept safe if she were ever too ill to manage them. She named a health care agent, recorded in the confidential part of the chart and not named here, and chose not to record other treatment preferences today. To be revisited yearly. **S**

## Guideline basis

- CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recomm Rep 2022;71(3):1-95)
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Seven-month review in the autumn with the PHQ-9, sputum culture, the second hepatitis B dose and the influenza vaccine. Hepatitis B, hepatitis C and HPV results by phone. Next preventive visit in one year. **S**
- Next scheduled visit 1845-10-19: seven-month review after an exacerbation: lungs, opioid therapy, mood, safety, weight, and vaccines. **S**
